203 related articles for article (PubMed ID: 17718852)
1. Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency.
Drouin J; Bilodeau S; Vallette S
Clin Genet; 2007 Sep; 72(3):175-82. PubMed ID: 17718852
[TBL] [Abstract][Full Text] [Related]
2. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.
Bilodeau S; Vallette-Kasic S; Gauthier Y; Figarella-Branger D; Brue T; Berthelet F; Lacroix A; Batista D; Stratakis C; Hanson J; Meij B; Drouin J
Genes Dev; 2006 Oct; 20(20):2871-86. PubMed ID: 17043312
[TBL] [Abstract][Full Text] [Related]
3. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
4. Low estriol levels in the maternal triple-marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene.
Weintrob N; Drouin J; Vallette-Kasic S; Taub E; Marom D; Lebenthal Y; Klinger G; Bron-Harlev E; Shohat M
Pediatrics; 2006 Feb; 117(2):e322-7. PubMed ID: 16390921
[TBL] [Abstract][Full Text] [Related]
5. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency.
Pulichino AM; Vallette-Kasic S; Couture C; Gauthier Y; Brue T; David M; Malpuech G; Deal C; Van Vliet G; De Vroede M; Riepe FG; Partsch CJ; Sippell WG; Berberoglu M; Atasay B; Drouin J
Genes Dev; 2003 Mar; 17(6):711-6. PubMed ID: 12651888
[TBL] [Abstract][Full Text] [Related]
6. [Tpit mutations reveal a new model of pituitary differentiation and account for isolated ACTH deficiency].
Pulichino AM; Vallette-Kasic S; Couture C; Brue T; Drouin J
Med Sci (Paris); 2004 Nov; 20(11):1009-13. PubMed ID: 15525497
[TBL] [Abstract][Full Text] [Related]
7. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
[TBL] [Abstract][Full Text] [Related]
9. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
[TBL] [Abstract][Full Text] [Related]
10. Pituitary transcription factors: from congenital deficiencies to gene therapy.
Quentien MH; Barlier A; Franc JL; Pellegrini I; Brue T; Enjalbert A
J Neuroendocrinol; 2006 Sep; 18(9):633-42. PubMed ID: 16879162
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH-deficiency patients with TPIT gene mutations.
Couture C; Saveanu A; Barlier A; Carel JC; Fassnacht M; Flück CE; Houang M; Maes M; Phan-Hug F; Enjalbert A; Drouin J; Brue T; Vallette S
J Clin Endocrinol Metab; 2012 Mar; 97(3):E486-95. PubMed ID: 22170728
[TBL] [Abstract][Full Text] [Related]
12. 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression.
Drouin J
J Mol Endocrinol; 2016 May; 56(4):T99-T112. PubMed ID: 26792828
[TBL] [Abstract][Full Text] [Related]
13. The TPIT gene mutation M86R associated with isolated adrenocorticotropin deficiency interferes with protein: protein interactions.
Vallette-Kasic S; Couture C; Balsalobre A; Gauthier Y; Metherell L; Dattani M; Drouin J
J Clin Endocrinol Metab; 2007 Oct; 92(10):3991-9. PubMed ID: 17652218
[TBL] [Abstract][Full Text] [Related]
14. [Isolated ACTH deficiency].
Nigawara T; Suda T
Nihon Rinsho; 2006 May; Suppl 1():58-62. PubMed ID: 16776093
[No Abstract] [Full Text] [Related]
15. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910
[TBL] [Abstract][Full Text] [Related]
16. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
[TBL] [Abstract][Full Text] [Related]
17. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
18. [Abnormalities in the development of adrenal gland].
Tanaka T; Umezawa A; Tsutsumi H
Nihon Rinsho; 2006 May; Suppl 1():756-9. PubMed ID: 16776268
[No Abstract] [Full Text] [Related]
19. Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach.
van Rossum EF; Lamberts SW
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):611-26. PubMed ID: 17161335
[TBL] [Abstract][Full Text] [Related]
20. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.
Heaney AP; Fernando M; Yong WH; Melmed S
Nat Med; 2002 Nov; 8(11):1281-7. PubMed ID: 12379847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
